The National Institute of General Medicine Sciences, National Institute of Health have granted Qrono, a Pittsburgh-based pharmaceutical company, a $256,000 Small Business Technology Transfer Phase I grant for the improvement of wet age-related macular degeneration treatments.
The grant will also help fund the company's work on long-acting injectable drug formulations.
The grant-funded research will be done in collaboration with The Little Lab of the Swanson School of Engineering at the University of Pittsburgh.
More Articles on Ophthalmology:
$600k Grant to Fund Telemedicine at Flaum Eye Institute
12 Statistics on Ophthalmologist Compensation by Setting
BIOLASE Earns US Patent for Laser Technologies
The grant will also help fund the company's work on long-acting injectable drug formulations.
The grant-funded research will be done in collaboration with The Little Lab of the Swanson School of Engineering at the University of Pittsburgh.
More Articles on Ophthalmology:
$600k Grant to Fund Telemedicine at Flaum Eye Institute
12 Statistics on Ophthalmologist Compensation by Setting
BIOLASE Earns US Patent for Laser Technologies